China's Fosun Pharma Takes On Roche with Biosimilar Launch - swissinfo.ch
China's Fosun Pharma Takes On Roche with Biosimilar Launch swissinfo.ch
(Bloomberg) -- After nearly two decades of dominance in treating lymphoma in China, Roche Holding AG is about to face direct competition from a Chinese ...
Comments
Post a Comment